In Vitro and in Vivo Evaluation of the Radiosensitizing Effect of a Selective FGFR Inhibitor (JNJ-42756493) for Rectal Cancer

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-2000-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models

International Journal of Cancer
Cancer ResearchOncology
2019English

In Vitro and in Vivo Superior Radiosensitizing Effect of Berbamine for Head and Neck Squamous Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2018English

Antitumor Activity of the Selective Cyclooxygenase-2 Inhibitor, Celecoxib, on Breast Cancer in Vitro and in Vivo

Cancer Cell International
Cancer ResearchOncologyGenetics
2012English

A Radiosensitizing Inhibitor of HIF-1 Alters the Optical Redox State of Human Lung Cancer Cells in Vitro

Scientific Reports
Multidisciplinary
2018English

In Vitro Evaluation of Radioprotective and Radiosensitizing Effects of Rituximab

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2008English

CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and in Vivo Characterization

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Selective FGFR Inhibitor BGJ398 Inhibits Phosphorylation of AKT and STAT3 and Induces Cytotoxicity in Sphere-Cultured Ovarian Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2017English

Cryopreserved Biopsy Tissues of Rectal Cancer Liver Metastasis for Assessment of Anticancer Drug Response In�vitro and In�vivo

Oncology Reports
MedicineCancer ResearchOncology
2019English

Synthesis and in Vitro/in Vivo Evaluation of the Antitrypanosomal Activity of 3-Bromoacivicin, a Potent CTP Synthetase Inhibitor

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy